The company said it is able to return the funds because of its improved financial performance in the third quarter and its expectation that its future performance will be strong.
“Our base business continued to improve as people returned to routine medical care and treatments and clinical trial studies resumed,” said LabCorp Chair and CEO Adam Schechter. “I want to thank our more than 70,000 employees around the world for all of their hard work and dedication.”
In the quarter ended Sept. 30, LabCorp saw its revenue increase to $3.9 billion, up $1 billion from the same quarter in 2019.
The diagnostic testing company ended the period with an operating income of $1.05 billion, compared to $339 million in the third quarter of 2019.
After factoring in expenses and investments, LabCorp reported a net income of $703.4 million in the third quarter. This compares to a $220.7 million net income in the three-month period one year prior.
More articles on healthcare finance:
New Hampshire health system files for bankruptcy
6 recent donations to hospitals, health systems
CHS records $112M profit, says it will sell 4 more hospitals by year-end
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
